大流行
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
接种疫苗
2019-20冠状病毒爆发
免疫
人口
免疫系统
生物
病毒学
免疫学
医学
环境卫生
疾病
病理
爆发
传染病(医学专业)
作者
Ranjeet Maurya,Uzma Shamim,Pallavi Mishra,Aparna Swaminathan,Aakarshan Raina,Bansidhar Tarai,Sandeep Budhiraja,Rajesh Pandey
标识
DOI:10.1128/spectrum.04292-22
摘要
The development of multiple vaccines against SARS-CoV-2 infection is an unprecedented milestone achieved globally. Immunization of the mass population is a rigorous process for getting the pandemic under control, yet continuous challenges are being faced, one of them being breakthrough infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI